Welcome : Guest

ARCA Biopharma, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about ARCA Biopharma, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 12 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-05086
Price: $600
Company Type: Public
Pages: 14
Date: November 2016
Market Data Tables: 12

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
  ARCA BIOPHARMA, INC. (USA) (Complete Report)Pages : 14|$ 600.00
1. COMPANY SNIPPETS......1
2. MAJOR PRODUCTS AND SERVICES......2
3. MARKET OVERVIEW......3
Biopharmaceuticals......3
Table 1: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......3
Cardiology......4
Table 2: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......4
Table 3: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......5
Table 4: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......6
Atrial Fibrillation......7
Table 5: Global Atrial Fibrillation / Electrophysiology Market (2014) in US$ Million......7
Table 6: Atrial Fibrillation Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for EP Ablation, EP Diagnostics, EP Mapping & Recording Systems, EP Mapping & Recording Systems, Access, ICE, and Others......8
4. COMPETITIVE LANDSCAPE......9
Biopharmaceuticals......9
Table 7: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......9
Table 8: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......10
Cardiology Therapeutics......11
Table 9: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......11
Cardio-Cerebral Vascular (CCV) Drugs......12
Table 10: Market Shares of Leading Cardio-Cerebral Vascular (CCV) Drugs Manufacturers in China (2015) - Percentage Share Breakdown by Value for Sihuan Pharmaceutical Holdings Group Ltd., Sanofi S.A., Qilu pharmaceutical Co., Ltd. and Others......12
Atrial Fibrillation......13
Table 11: Market Shares of Leading Atrial Fibrillation / Electrophysiology Device Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Biosense Webster, Inc., Boston Scientific Corporation, C. R. Bard, Inc., Medtronic, Inc., and St. Jude Medical, Inc.......13
Table 12: Market Shares of Leading Atrial Fibrillation Device Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Boston Scientific Corporation, and Medtronic, Inc.......14